These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7575600)

  • 1. Structure of prejunctional receptor binding analog of human neuropeptide Y dimer ANA-NPY.
    Barden JA
    Biochem Biophys Res Commun; 1995 Oct; 215(1):264-71. PubMed ID: 7575600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y.
    Uegaki K; Murase S; Nemoto N; Kobayashi Y; Yoshikawa S; Yumoto N
    Biochem Biophys Res Commun; 1997 Dec; 241(3):737-43. PubMed ID: 9434778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
    Lerch M; Mayrhofer M; Zerbe O
    J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment.
    Doughty MB; Hu L
    Biopolymers; 1993 Aug; 33(8):1195-206. PubMed ID: 8364154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the presynaptic (Y2) receptor-specific neuropeptide Y analog ANA-NPY.
    Barden JA; Cuthbertson RM; Potter EK
    Biochim Biophys Acta; 1995 Jul; 1250(1):83-9. PubMed ID: 7612657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y.
    Yumoto N; Murase S; Hattori T; Yamamoto H; Tatsu Y; Yoshikawa S
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1490-5. PubMed ID: 8250906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
    Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
    Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
    Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
    Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of neuropeptide Y and Hsp90 through a novel peptide binding region.
    Ishiwatari-Hayasaka H; Maruya M; Sreedhar AS; Nemoto TK; Csermely P; Yahara I
    Biochemistry; 2003 Nov; 42(44):12972-80. PubMed ID: 14596612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity analysis of N-acetyl [Leu(28,31)] NPY 24-36: a potent neuropeptide Y Y(2) receptor agonist.
    Smith-White MA; Potter EK
    Neuropeptides; 1999 Dec; 33(6):526-33. PubMed ID: 10657536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-helical small molecular size analogues of neuropeptide Y: structure-activity relationships.
    Jung G; Beck-Sickinger AG; Dürr H; Gaida W; Schnorrenberg G
    Biopolymers; 1991 May; 31(6):613-9. PubMed ID: 1657233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
    Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
    J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
    Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
    Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor.
    Rist B; Wieland HA; Willim KD; Beck-Sickinger AG
    J Pept Sci; 1995; 1(5):341-8. PubMed ID: 9223013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity displacement of [(3)H]NPY binding to the crude venom of conus anemone by insect neuropeptides.
    Le MT; Vanderheyden PM; De Backer JP; Vanquelin G; Broeck JV
    Biochem Biophys Res Commun; 1999 Aug; 262(1):180-6. PubMed ID: 10448089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
    Beck-Sickinger AG; Jung G
    Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
    Fournier A; Gagnon D; Quirion R; Cadieux A; Dumont Y; Pheng LH; St-Pierre S
    Mol Pharmacol; 1994 Jan; 45(1):93-101. PubMed ID: 8302286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.